|
|
||||||||
Received December 21, 2007. Accepted for publication March 16, 2008.
Acknowledgments: We thank M. Estes for critical review of the manuscript.
Financial support: Nikos Vasilakis was supported by the Centers for Disease Control and Prevention Fellowship Training Program in Vector-Borne Infectious Diseases (T01/CCT622892).
Disclosure: The authors have no conflicting financial interests.
* Address correspondence to Scott C. Weaver, Center for Biodefense and Emerging Infectious Diseases, and Department of Pathology Keiller 3.135, 301 University Boulevard, University of Texas Medical Branch, Galveston, TX 77555-0609. E-mail: sweaver{at}utmb.edu
Authors addresses: Nikos Vasilakis, Center for Vaccine Research, University of Pittsburgh, 9051 Biomedical Sciences Tower 3, 3501 Fifth Avenue, Pittsburgh, PA 15261. Anna P. Durbin, Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Hampton House, 624 North Broadway, Baltimore, MD 21205. Amelia P. A. Travassos da Rosa, Robert B. Tesh, and Scott C. Weaver, Center for Biodefense and Emerging Infectious Diseases, and Department of Pathology, University of Texas Medical Branch, 301 University Boulevard, Keiller Building, Galveston, TX 77555-0609. Jorge L. Munoz-Jordan, Molecular Virology and Surveillance Laboratory, Center for Disease Control and Prevention, Dengue Branch, San Juan, PR 00920.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |